Redhill Capital is an early-stage venture capital firm based in Guangzhou, China, founded in 2018. It specializes in investing in the medical industry, particularly focusing on life sciences, healthcare, and medical technology sectors. The firm manages multiple funds, including the Redhill Capital Medical RMB Fund II and Redhill Technology Innovation Venture Fund III, which target investment opportunities within China. Redhill Capital aims to support innovative companies in the healthcare field, contributing to advancements in medical devices and technologies.
Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment.
Precision Autoimmune Therapeutics
Venture Round in 2022
Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.
Provider of an AI-enabled drug and disease discovery platform. The company provides a drug and disease discovery platform empowered by machine learning and AI to discover novel disease targets, screen for potential drugs, repurpose existing drugs for new indication and optimization ADMET property prediction, enabling a more efficient way to generate new insights and discover more effective medicines to decipher disease biology.
Xinji Pharmaceuticals is mainly engaged in the R&D of new drug preparations and drug release systems. The company is especially involved in the application and promotion of drug-controlled release, sustained release, and targeted drug release technologies in the industrialization of biomedicine.
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.
Vibrant
Funding Round in 2020
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.
GenAssist Therapeutics is a biotechnology company founded in July 2020 that specializes in developing gene therapy drugs using advanced base editing technology. The company focuses on addressing genetic diseases, particularly neuromuscular disorders such as Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA), for which effective treatments are currently lacking. By employing Targeted AID-based Mutagenesis (TAM) technology, GenAssist aims to precisely repair disease-causing genes in situ, offering the potential for permanent cures. The company possesses global intellectual property rights for its innovative approach, reflecting its commitment to advancing gene editing therapies across a range of genetic conditions.
Hunan Cofoe Medical Technology Development Co., Ltd. develops and manufactures home rehabilitation products. It offers products, such as wheelchairs, blood glucose meters, blood pressure monitors, oxygen generators, and hearing aids and crutches. Hunan Cofoe Medical Technology Development Co., Ltd. was founded in 2009 and is based in Changsha, China.
Changzhou Zhishan Medical Technology Co., Ltd. was established in May 2017. It was founded by domestic and international medical experts and senior medical equipment practitioners. It is the first high-tech company in China focusing on diabetes and weight loss. The company is headquartered in the beautiful West Taihu Hi-Tech Industrial Park in Changzhou. The factory has established a 100,000-level purification workshop and established a research and development center in Shanghai Zhangjiang - Shanghai Panda Medical Technology Co., Ltd. Zhishan Medical is engaged in the research and development and industrialization of non-invasive medical devices.
Mingyitang Hospital
Series A in 2018
Mingyitang Hospital is a traditional medicine clinic operator.
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.